Sialadenosis in bulimia. A new treatment
P. S. Mehler and J. A. Wallace
Department of Internal Medicine, Columbine Hospital, Littleton, CO 80126.
OBJECTIVE--To see whether a cholinomimetic medication would help resolve
the parotid gland enlargement associated with self-induced vomiting in
bulimic patients. SETTING/DESIGN--The medication was administered on an
inpatient eating disorder unit to bulimic patients with refractory
sialadenosis. INTERVENTION--Pilocarpine hydrochloride drops were
administered orally at a dosage of 1.25 to 5.0 mg/d until the parotid gland
enlargement was significantly reduced. RESULTS--There was a marked
diminution in the size of the parotid gland enlargement.
CONCLUSION--Pilocarpine has proved to be beneficial in the treatment of
sialadenosis in bulimic patients.
